Browse 8 Pharmaceutical companies funded by Insight Partners. See funding amounts, founder contacts, and investment details.
Superluminal Medicines develops small-molecule therapeutics using AI, biology, and chemistry.
Graph AI develops a pharmacovigilance platform that supports patient safety and regulatory operations across the pharmaceutical lifecycle.
PhaseV provides AI-driven solutions for efficient clinical development and operations.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.
The industry's first agentic AI manufacturing platform built for a world beyond paper and legacy MES
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
Florence is a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.
View all companies funded by Insight Partners across every industry and funding stage.
View Full Insight Partners Portfolio